Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: A preliminary study of the correlations between quantitative parameters and clinical stage

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 4, 2014, Pages 940-948

  Zheng, Dechun ^a   Chen, Yunbin ^a,b   Chen, Ying ^b   Xu, Luying ^b   Chen, Weibo ^c   Yao, Yiqi ^b   Du, Zhongshi ^b   Deng, Xiaohong ^b   Chan, Queenie ^c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUJIAN PROVINCIAL CANCER HOSPITAL   (China)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

clinical staging; DCE MRI; hypoxia; nasopharyngeal carcinoma

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORRELATIONAL STUDY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TUMOR VOLUME;

CLINICAL STAGING; DCE-MRI; HYPOXIA; NASOPHARYNGEAL CARCINOMA;

CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 84897028491     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24249     Document Type: Article

References (30)

1. Xiao WW, Lu TX, Zhao C, Su SF,. Impact of intensity-modulated radiotherapy on the 6th edition of UICC/AJCC staging system in nasopharyngeal carcinoma. Chin J Radiat Oncol 2010; 19: 181-184.
2. Wan XB, Fan XJ, Chen MY, et al. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 2010; 6: 395-404.
3. King AD, Bhatia KS,. Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck. World J Radiol 2010; 2: 159-165.
4. Comoretto M, Balestreri L, Borsatti E,. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 2008; 249: 203-211.
5. Liao XB, Mao YP, Liu LZ, et al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 2008; 72: 1368-1377.
6. Rieger J, Bahr O, Muller K, Franz K, Steinbach J, Hattingen E,. Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients. J Neurooncol 2010; 99: 49-56.
7. Gulliksrud K, Hompland T, Galappathi K, Rofstad EK,. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011; 101: 217-222.
8. Ellingsen C, Egeland TA, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK,. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009; 73: 838-845.
9. Jansen JF, Schoder H, Lee NY, et al. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 2010; 77: 1403-1410.
10. Huang B, Wong CS, Whitcher B, et al. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol 2013 [Epub ahead of print]. doi: 10.1007/s00330-012-2740-7.
11. Kim S, Loevner LA, Quon H, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010; 31: 262-268.
12. Gulliksrud K, Ovrebø KM, Mathiesen B, Rofstad EK,. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011; 98: 360-364.
13. Yopp AC, Schwartz LH, Kemeny N, et al. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Ann Surg Oncol 2011; 18: 2192-2199.
14. Chinese Nasopharyngeal Carcinoma Clinical Staging Working Committee. Revised report about nasopharyngeal carcinoma of the 92nd staging. Chin J Radiat Oncol 2009; 18: 2-6.
15. Yunbin Chen, Biling Liang,. Introduction of 2008 nasopharyngeal carcinoma staging system in China. Chin J Radiol 2009; 43: 1119-1120.
16. Wang HZ, Riederer SJ, Lee JN,. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987; 5: 399-416.
17. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: correlation of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998; 171: 941-949.
18. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J,. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994; 31: 567-571.
19. Tofts PS, Brix G, Buckley DL, et al. estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
20. Murase K,. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 2004; 51: 858-862.
21. Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK,. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts. Magn Reson Med 2004; 52: 269-276.
22. Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL,. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 2010; 16: 186-192.
23. El Khouli RH, Macura KJ, Kamel IR, Jacobs MA, Bluemke DA,. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol 2011; 197: 1498-1505.
24. Langer DL, van der Kwast TH, Evans AJ, et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 2010; 255: 485-494.
25. Yao WW, Zhang H, Ding B, et al. Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features. Radiol Med 2011; 116: 366-374.
26. Ovrebo KM, Hompland T, Mathiesen B, Rofstad EK,. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2012; 102: 429-435.
27. Halle C, Andersen E, Lando M, et al. Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. Cancer Res 2012; 72: 5285-5295.
28. Nguyen DX, Bos PD, Massague J,. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9: 274-284.
29. Lorusso G, Ruegg C,. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 2008; 130: 1091-1103.
30. Prager GW, Poettler M, Unseld M, Zielinski CC,. Angiogenesis in cancer: anti-VEGF escape mechanisms. Transl Lung Cancer Res 2012; 1: 14-25.